Xtandi 40 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBA4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,266
Award facts
- Contract value 100% obligated
- $13,266.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, for Xtandi 40 mg tablets (120-count units) with a ceiling value of $13,266.48 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order carries an ultimate completion date of March 23, 2026, and is priced on a firm fixed-price basis. No set-aside was used for this delivery order.
Quick answers
Who was awarded contract SPE2DR26FFBA4?
SPE2DR26FFBA4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 20, 2026.
How much is contract SPE2DR26FFBA4 worth?
The government has obligated $13,266 on SPE2DR26FFBA4.
Is contract SPE2DR26FFBA4 an order under another contract?
Yes. SPE2DR26FFBA4 is a delivery order under SPE2DR25D9225, an indefinite delivery contract.
Was contract SPE2DR26FFBA4 competed?
The extent of competition for SPE2DR26FFBA4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award